​

NeuroOne Medical (NMTC) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChartTranscripts

NMTC Stock Forecast

NeuroOne Medical (NMTC) stock forecast, based on 4 Wall Street analysts, predicts a 12-month average price target of $5.00, with a high of $5.00 and a low of $5.00. This represents a 566.67% increase from the last price of $0.75.

- $1 $2 $3 $4 $5 $6 High: $5 Avg: $5 Low: $5 Last Closed Price: $0.75

NMTC Stock Rating

NeuroOne Medical stock's rating consensus is Buy, based on 4 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 3 Buy (75.00%), 1 Hold (25.00%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).

Buy
Total 4 0 1 3 Strong Sell Sell Hold Buy Strong Buy

NMTC Price Target Upside V Benchmarks

TypeNameUpside
StockNeuroOne Medical566.67%
SectorHealthcare Stocks 15.45%
IndustryMedical Device Stocks9.18%

Price Target Trends

1M3M12M
# Anlaysts-11
Avg Price Target-$5.00$5.00
Last Closing Price$0.75$0.75$0.75
Upside/Downside-566.67%566.67%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Nov, 2612---3
Oct, 2612---3
Sep, 2612---3
Aug, 2612---3
Jul, 2612---3
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Aug 14, 2026Maxim Group$5.00$1.81176.24%566.67%
Sep 09, 2025Maxim Group$3.00$0.89237.08%300.00%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change

Financial Forecast

EPS Forecast

Sep 22 Sep 23 Sep 24 Sep 25 Sep 26
Sep 22Sep 23Sep 24Sep 25Sep 26
Reported$-0.63$-0.65$-0.46$-0.09-
Avg Forecast$-0.65$-0.70$-0.41$-0.31$-0.18
High Forecast$-0.65$-0.70$-0.41$-0.31$-0.18
Low Forecast$-0.65$-0.70$-0.41$-0.31$-0.18
Surprise %-3.08%-7.14%12.20%-70.97%-

Revenue Forecast

$0 $4M $8M $12M $16M $20M Sep 22 Sep 23 Sep 24 Sep 25 Sep 26
Sep 22Sep 23Sep 24Sep 25Sep 26
Reported$171.17K$1.95M$3.45M$9.10M-
Avg Forecast$1.90M$3.50M$5.50M$10.20M$15.20M
High Forecast$1.90M$3.50M$5.50M$10.20M$15.20M
Low Forecast$1.90M$3.50M$5.50M$10.20M$15.20M
Surprise %-90.99%-44.22%-37.22%-10.81%-

Net Income Forecast

$-20M $-16M $-12M $-8M $-4M $0 Sep 22 Sep 23 Sep 24 Sep 25 Sep 26
Sep 22Sep 23Sep 24Sep 25Sep 26
Reported$-10.00M$-11.86M$-12.32M$-3.61M-
Avg Forecast$-11.78M$-18.60M$-10.97M$-8.30M$-4.82M
High Forecast$-11.78M$-18.60M$-10.97M$-8.30M$-4.82M
Low Forecast$-11.78M$-18.60M$-10.97M$-8.30M$-4.82M
Surprise %-15.10%-36.24%12.26%-56.54%-

NMTC Forecast FAQ

Is NeuroOne Medical stock a buy?

NeuroOne Medical stock has a consensus rating of Buy, based on 4 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 3 Buy, 1 Hold, 0 Sell, and 0 Strong Sell, reflecting a consensus that NeuroOne Medical is a favorable investment for most analysts.

What is NeuroOne Medical's price target?

NeuroOne Medical's price target, set by 4 Wall Street analysts, averages $5 over the next 12 months. The price target range spans from $5 at the low end to $5 at the high end, suggesting a potential 566.67% change from the previous closing price of $0.75.

How does NeuroOne Medical stock forecast compare to its benchmarks?

NeuroOne Medical's stock forecast shows a 566.67% upside, outperforming the average forecast for the healthcare stocks sector (15.45%) and outperforming the medical device stocks industry (9.18%).

What is the breakdown of analyst ratings for NeuroOne Medical over the past three months?

  • November 2026: 33.33% Strong Buy, 66.67% Buy, 0% Hold, 0% Sell, 0% Strong Sell.
  • October 2026: 33.33% Strong Buy, 66.67% Buy, 0% Hold, 0% Sell, 0% Strong Sell.
  • September 2026: 33.33% Strong Buy, 66.67% Buy, 0% Hold, 0% Sell, 0% Strong Sell.

What is NeuroOne Medical’s EPS forecast?

NeuroOne Medical's average annual EPS forecast for its fiscal year ending in September 2026 is $-0.18, marking a 100.00% increase from the reported $-0.09 in 2025..

What is NeuroOne Medical’s revenue forecast?

NeuroOne Medical's average annual revenue forecast for its fiscal year ending in September 2026 is $15.2M, reflecting a 67.08% increase from the reported $9.1M in 2025.

What is NeuroOne Medical’s net income forecast?

NeuroOne Medical's net income forecast for the fiscal year ending in September 2026 stands at $-4.817M, representing an 33.61% increase from the reported $-3.605M in 2025.